Fighting for every beat: cardiac therapies in Duchenne muscular dystrophy. [PDF]
Muchir A.
europepmc +1 more source
Histone deacetylases in Duchenne muscular dystrophy: a role in the mechanism of disease and a target for inhibition. [PDF]
Bertoldi M +9 more
europepmc +1 more source
The Role of Systemic Inflammatory Indices in Predicting Cardiovascular Involvement in Children with Duchenne Muscular Dystrophy. [PDF]
Altınok Eİ, Kasar T.
europepmc +1 more source
Endocrine and metabolic complications in a national cohort of Slovene children and adolescents with Duchenne muscular dystrophy: real-world criteria for transition to vamorolone therapy. [PDF]
Jazbinšek S +6 more
europepmc +1 more source
Related searches:
Assessing the Appropriateness of the EQ-5D for Duchenne Muscular Dystrophy: A Patient-Centered Study
Medical decision making, 2021Background Duchenne muscular dystrophy is a rare degenerative neuromuscular disorder with pediatric onset. Recent approvals in Duchenne have placed attention on the economic evaluation in pricing and reimbursement decisions across a range of rare ...
Norah L. Crossnohere +4 more
semanticscholar +1 more source
Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy
Muscle and Nerve, 2020We studied neurodevelopmental and behavioral/emotional symptoms in patients with Duchenne muscular dystrophy (DMD).
A. Darmahkasih +6 more
semanticscholar +1 more source
Golodirsen for Duchenne muscular dystrophy.
Drugs of Today, 2020Duchenne muscular dystrophy (DMD) is a life-shortening X-linked genetic disorder characterized by progressive wasting and weakening of muscles in boys. Loss-of-function mutations in the DMD gene, which codes for dystrophin, lead to this disease.
S. Anwar, T. Yokota
semanticscholar +1 more source

